Blog icon

Our biologics capabilities

CSIRO’s biologics facilities play a vital role in the biomedical research industry. Our esteemed scientists and world-class facilities provide companies and other research organisations the opportunity to produce biologics at the scale and quality required for pre-clinical and clinical applications.

Biologics capabilities

Our researchers and unique facilities play a vital role in the biomedical ecosystem. We partner with businesses and produce biologics at the scale and quality required for pre-clinical and clinical applications.

Manufacturing a COVID-19 vaccine

How do we produce a COVID-19 vaccine that is safe, effective and can be mass-produced? We take you into our labs to find out!

Our medical research

We deliver innovation to Australia's food, health, medical and wellness industries, resulting in significant health and economic benefits for Australians.

Biomedical

We work with biomedical companies to deliver new medical treatments and technologies that benefit millions of people in Australia and overseas, helping them live longer, healthier and more productive lives.

Diagnostics

We’re developing innovative solutions to better detect and prevent chronic illnesses including cancer, Alzheimer’s and metabolic diseases.

Diseases

We have a long and successful history in understanding complex diseases in humans. Through our research we investigate the transfer of disease from animals to humans, how to tackle infectious diseases like COVID-19, as well as discovering new ways of detecting disease in the human body.

Vaccines and drugs

CSIRO is involved in research supporting the development and evaluation of vaccines and drugs for diseases. We are playing a critical role in the rapid global response to find a COVID-19 vaccine.

Our biologics capabilities

CSIRO’s biologics facilities play a vital role in the biomedical research industry. Our esteemed scientists and world-class facilities provide companies and other research organisations the opportunity to produce biologics at the scale and quality required for pre-clinical and clinical applications.

Biologics capabilities

Our researchers and unique facilities play a vital role in the biomedical ecosystem. We partner with businesses and produce biologics at the scale and quality required for pre-clinical and clinical applications.

Manufacturing a COVID-19 vaccine

How do we produce a COVID-19 vaccine that is safe, effective and can be mass-produced? We take you into our labs to find out!

Our biologics capabilities

CSIRO’s biologics facilities play a vital role in the biomedical research industry. Our esteemed scientists and world-class facilities provide companies and other research organisations the opportunity to produce biologics at the scale and quality required for pre-clinical and clinical applications.

Biologics capabilities

Our researchers and unique facilities play a vital role in the biomedical ecosystem. We partner with businesses and produce biologics at the scale and quality required for pre-clinical and clinical applications.

Manufacturing a COVID-19 vaccine

How do we produce a COVID-19 vaccine that is safe, effective and can be mass-produced? We take you into our labs to find out!

Our medical research

We deliver innovation to Australia's food, health, medical and wellness industries, resulting in significant health and economic benefits for Australians.

Biomedical

We work with biomedical companies to deliver new medical treatments and technologies that benefit millions of people in Australia and overseas, helping them live longer, healthier and more productive lives.

Diagnostics

We’re developing innovative solutions to better detect and prevent chronic illnesses including cancer, Alzheimer’s and metabolic diseases.

Diseases

We have a long and successful history in understanding complex diseases in humans. Through our research we investigate the transfer of disease from animals to humans, how to tackle infectious diseases like COVID-19, as well as discovering new ways of detecting disease in the human body.

Vaccines and drugs

CSIRO is involved in research supporting the development and evaluation of vaccines and drugs for diseases. We are playing a critical role in the rapid global response to find a COVID-19 vaccine.

Our medical research

We deliver innovation to Australia's food, health, medical and wellness industries, resulting in significant health and economic benefits for Australians.

Biomedical

We work with biomedical companies to deliver new medical treatments and technologies that benefit millions of people in Australia and overseas, helping them live longer, healthier and more productive lives.

Diagnostics

We’re developing innovative solutions to better detect and prevent chronic illnesses including cancer, Alzheimer’s and metabolic diseases.

Diseases

We have a long and successful history in understanding complex diseases in humans. Through our research we investigate the transfer of disease from animals to humans, how to tackle infectious diseases like COVID-19, as well as discovering new ways of detecting disease in the human body.

Vaccines and drugs

CSIRO is involved in research supporting the development and evaluation of vaccines and drugs for diseases. We are playing a critical role in the rapid global response to find a COVID-19 vaccine.

Biomedical Materials Translation Facility

CSIRO's Biomedical Materials Translational Facility (BMTF) helps Medtech companies turn new discoveries into market ready products. It has the capability and equipment needed to develop a biomedical product though prototyping, scale-up, pre-clinical testing and industry evaluation and offers access to ISO 9001, ISO 17025 and GLP.

Medtech to market

CSIRO's Biomedical Materials Translational Facility (BMTF) helps medtech companies turn new discoveries into market ready products.

Sidelining delays in diagnosing concussion

We're working on a game-changing new device that could assist first responders to diagnose traumatic brain injuries on the spot.

Golden eye

How we're using gold nano-particles to help treat age-related macular degeneration.

Biomedical Materials Translation Facility

CSIRO's Biomedical Materials Translational Facility (BMTF) helps Medtech companies turn new discoveries into market ready products. It has the capability and equipment needed to develop a biomedical product though prototyping, scale-up, pre-clinical testing and industry evaluation and offers access to ISO 9001, ISO 17025 and GLP.

Medtech to market

CSIRO's Biomedical Materials Translational Facility (BMTF) helps medtech companies turn new discoveries into market ready products.

Sidelining delays in diagnosing concussion

We're working on a game-changing new device that could assist first responders to diagnose traumatic brain injuries on the spot.

Golden eye

How we're using gold nano-particles to help treat age-related macular degeneration.

Biomedical Materials Translation Facility

CSIRO's Biomedical Materials Translational Facility (BMTF) helps Medtech companies turn new discoveries into market ready products. It has the capability and equipment needed to develop a biomedical product though prototyping, scale-up, pre-clinical testing and industry evaluation and offers access to ISO 9001, ISO 17025 and GLP.

Penthrox green whistle

We helped Medical Development International move into the European market by creating a new, scalable and reliable manufacturing process for their Penthrox 'green whistle' pain-relieving drug.

Heel implant

We partnered with Victorian biotech company Anatomics and St Vincent's Hospital in a world-first surgery to assist a cancer patient.

3D Silicone Printing

Developing next generation silicones for 3D printing

Antibody Polymers

RAFT is our amazing polymer synthesiser that can be used for all kinds of things. Right now we’re creating targeted cancer treatment to help treat a range of solid tumour cancers.

Coral sunscreen

Together with biotechnology company Coral Sunscreen we are helping create the world's first sunscreen inspired by the Great Barrier Reef.

Biologics capabilities

Our researchers and unique facilities play a vital role in the biomedical ecosystem. We partner with businesses and produce biologics at the scale and quality required for pre-clinical and clinical applications.

Biomedical Materials Translation Facility

CSIRO's Biomedical Materials Translational Facility (BMTF) helps Medtech companies turn new discoveries into market ready products. It has the capability and equipment needed to develop a biomedical product though prototyping, scale-up, pre-clinical testing and industry evaluation and offers access to ISO 9001, ISO 17025 and GLP.

Penthrox green whistle

We helped Medical Development International move into the European market by creating a new, scalable and reliable manufacturing process for their Penthrox 'green whistle' pain-relieving drug.

Heel implant

We partnered with Victorian biotech company Anatomics and St Vincent's Hospital in a world-first surgery to assist a cancer patient.

3D Silicone Printing

Developing next generation silicones for 3D printing

Antibody Polymers

RAFT is our amazing polymer synthesiser that can be used for all kinds of things. Right now we’re creating targeted cancer treatment to help treat a range of solid tumour cancers.

Coral sunscreen

Together with biotechnology company Coral Sunscreen we are helping create the world's first sunscreen inspired by the Great Barrier Reef.

Biologics capabilities

Our researchers and unique facilities play a vital role in the biomedical ecosystem. We partner with businesses and produce biologics at the scale and quality required for pre-clinical and clinical applications.

Garden weeds for skin cancer

We're helping an Australian company manufacture a skin cancer treatment out of a common weed.

PolyNovo

We've been developing new non-toxic and bio-non-reactive polymers to treat burns, mend bone and heal cartilage.

Stem cell safety

We have developed the first safety test specifically for human induced pluripotent stem cells.

Small molecule drug discovery

CSIRO supports early-stage drug discovery, focussing on target biology, synthetic and medicinal chemistry, in vitro and in vivo testing and process development for up-scale manufacturing.

Rib and sternum implant

In a world-first surgery, a Spanish cancer patient has received a 3D printed titanium sternum and rib implant.

Titanium Polymer Sternum

We've partnered with Victorian biotechnical company Anatomics to deliver a custom-made sternum in a world-first surgery.

Contact us

Find out how we can help you and your business. Get in touch using the form below and our experts will get in contact soon!

CSIRO will handle your personal information in accordance with the Privacy Act 1988 (Cth) and our Privacy Policy.


First name must be filled in

Surname must be filled in

I am representing *

Please choose an option

Please provide a subject for the enquriy

0 / 100

We'll need to know what you want to contact us about so we can give you an answer

0 / 1900

You shouldn't be able to see this field. Please try again and leave the field blank.